Lung cancer progression and metastasis from the prognostic point of view

Clinical and Experimental Metastasis

Volumn 27, Issue 6, 2010, Pages 389-397

  Inamura, Kentaro ^a   Ishikawa, Yuichi ^a  

^a CANCER INSTITUTE   (Japan)

Author keywords

Comparative genomic hybridization; Gene expression; Loss of heterozygosity analysis; Lung cancer; Metastasis; Prognosis

Indexed keywords

CANCER GROWTH; CARCINOGENESIS; COMPARATIVE GENOMIC HYBRIDIZATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CANCER; LYMPH NODE METASTASIS; METASTASIS; NEUROENDOCRINE TUMOR; PROGNOSIS; REVIEW; SQUAMOUS CELL CARCINOMA; TUMOR CELL; TUMOR CELL LINE; TUMOR CLASSIFICATION; ADENOCARCINOMA; CLASSIFICATION; DISEASE COURSE; GENETICS; LUNG TUMOR; MORTALITY; PATHOLOGY;

HOMEODOMAIN PROTEIN; HOXB2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; HOMEODOMAIN PROTEINS; HUMANS; LUNG NEOPLASMS; NEOPLASM METASTASIS; NEUROENDOCRINE TUMORS; PROGNOSIS; TRANSCRIPTION FACTORS;

EID: 77955876787     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-010-9313-4     Document Type: Review

References (27)

1. MD Brundage D Davies WJ Mackillop 2002 Prognostic factors in non-small cell lung cancer: a decade of progress Chest 122 3 1037 1057 10.1378/chest.122.3.1037 10.1378/chest.122.3.1037 12226051
2. T Miyoshi Y Satoh S Okumura, et al. 2003 Early-stage lung adenocarcinomas with a micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis Am J Surg Pathol 27 1 101 109 10.1097/00000478-200301000-00011 10.1097/00000478-200301000-00011 12502932
3. K Inamura T Shimoji H Ninomiya, et al. 2007 A metastatic signature in entire lung adenocarcinomas irrespective of morphological heterogeneity Hum Pathol 38 5 702 709 10.1016/j.humpath.2006.11.019 10.1016/j.humpath.2006.11.019 17376511
4. ME Garber OG Troyanskaya K Schluens, et al. 2001 Diversity of gene expression in adenocarcinoma of the lung Proc Natl Acad Sci USA 98 24 13784 13789 10.1073/pnas.241500798 10.1073/pnas.241500798 1:CAS:528: DC%2BD3MXovVynt7o%3D 11707590
5. A Bhattacharjee WG Richards J Staunton, et al. 2001 Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses Proc Natl Acad Sci USA 98 24 13790 13795 10.1073/pnas.191502998 10.1073/pnas.191502998 1:CAS:528:DC%2BD3MXovVynt7s%3D 11707567
6. DG Beer SL Kardia CC Huang, et al. 2002 Gene-expression profiles predict survival of patients with lung adenocarcinoma Nat Med 8 8 816 824 1:CAS:528:DC%2BD38Xls12msLk%3D 12118244
7. S Ramaswamy KN Ross ES Lander, et al. 2003 A molecular signature of metastasis in primary solid tumors Nat Genet 33 1 49 54 10.1038/ng1060 10.1038/ng1060 1:CAS:528:DC%2BD38XpvVeqs7w%3D 12469122
8. LA Liotta EC Kohn 2003 Cancer's deadly signature Nat Genet 33 1 10 11 10.1038/ng0103-10 10.1038/ng0103-10 1:CAS:528:DC%2BD38XpvVeru7o%3D 12509774
9. A Potti S Mukherjee R Petersen, et al. 2006 A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer N Engl J Med 355 6 570 580 10.1056/NEJMoa060467 10.1056/NEJMoa060467 1:CAS:528:DC%2BD28XotVKnu7g%3D 16899777
10. Z Sun MC Aubry C Deschamps, et al. 2006 Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: an analysis of 5018 hospital- and 712 population-based cases J Thoracic Cardiovasc Surg 131 5 1014 1020 10.1016/j.jtcvs.2005.12.057 10.1016/j.jtcvs.2005.12.057
11. K Inamura T Fujiwara Y Hoshida, et al. 2005 Two subclasses of lung squamous cell carcinoma with different gene expression profiles and prognosis identified by hierarchical clustering and non-negative matrix factorization Oncogene 24 47 7105 7113 10.1038/sj.onc.1208858 10.1038/sj.onc.1208858 1:CAS:528:DC%2BD2MXhtFCru77E 16007138
12. JP Brunet P Tamayo TR Golub, et al. 2004 Metagenes and molecular pattern discovery using matrix factorization Proc Natl Acad Sci USA 101 12 4164 4169 10.1073/pnas.0308531101 10.1073/pnas.0308531101 1:CAS:528:DC%2BD2cXivFartrc%3D 15016911
13. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC (2004) World health organization classification of tumours: pathology and genetics of tumours of the lung, pleural, thymus and heart. Springer, Berlin
14. MH Jones C Virtanen D Honjoh, et al. 2004 Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles Lancet 363 9411 775 781 10.1016/S0140-6736(04)15693-6 10.1016/S0140-6736(04) 15693-6 1:CAS:528:DC%2BD2cXhvVOqtrg%3D 15016488
15. C Virtanen Y Ishikawa D Honjoh, et al. 2002 Integrated classification of lung tumors and cell lines by expression profiling Proc Natl Acad Sci USA 99 19 12357 12362 10.1073/pnas.192240599 10.1073/pnas.192240599 1:CAS:528: DC%2BD38XntlCksbw%3D 12218176
16. E Sasatomi SD Finkelstein JD Woods, et al. 2002 Comparison of accumulated allele loss between primary tumor and lymph node metastasis in stage II non-small cell lung carcinoma: implications for the timing of lymph node metastasis and prognostic value Cancer Res 62 9 2681 2689 1:CAS:528: DC%2BD38XjtlGrt7Y%3D 11980668
17. Y Kang PM Siegel W Shu, et al. 2003 A multigenic program mediating breast cancer metastasis to bone Cancer Cell 3 6 537 549 10.1016/S1535-6108(03)00132-6 10.1016/S1535-6108(03)00132-6 1:CAS:528:DC%2BD3sXltlSmsL4%3D 12842083
18. S Kakiuchi Y Daigo T Tsunoda, et al. 2003 Genome-wide analysis of organ-preferential metastasis of human small cell lung cancer in mice Mol Cancer Res 1 7 485 499 1:CAS:528:DC%2BD3sXjvVSltL0%3D 12754296
19. LJ van 't Veer H Dai MJ van de Vijver, et al. 2002 Gene expression profiling predicts clinical outcome of breast cancer Nature 415 6871 530 536 10.1038/415530a 10.1038/415530a 11823860
20. H Terasaki T Niki Y Matsuno, et al. 2003 Lung adenocarcinoma with mixed bronchioloalveolar and invasive components: clinicopathological features, subclassification by extent of invasive foci, and immunohistochemical characterization Am J Surg Pathol 27 7 937 951 10.1097/00000478-200307000-00009 10.1097/00000478-200307000-00009 12826886
21. D Segara AV Biankin JG Kench, et al. 2005 Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia Clin Cancer Res 11 9 3587 3596 10.1158/1078-0432.CCR-04-1813 10.1158/1078-0432.CCR-04-1813 1:CAS:528:DC%2BD2MXjslOqtbk%3D 15867264
22. T Kikuchi Y Daigo T Katagiri, et al. 2003 Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs Oncogene 22 14 2192 2205 10.1038/sj.onc.1206288 10.1038/sj.onc.1206288 1:CAS:528:DC%2BD3sXislyitbY%3D 12687021
23. A D'Arrigo C Belluco A Ambrosi, et al. 2005 Metastatic transcriptional pattern revealed by gene expression profiling in primary colorectal carcinoma Int J Cancer 115 2 256 262 10.1002/ijc.20883 10.1002/ijc.20883 15688387
24. L Xi J Lyons-Weiler MC Coello, et al. 2005 Prediction of lymph node metastasis by analysis of gene expression profiles in primary lung adenocarcinomas Clin Cancer Res 11 11 4128 4135 10.1158/1078-0432.CCR-04-2525 10.1158/1078-0432.CCR-04-2525 1:CAS:528:DC%2BD2MXks1Gks7s%3D 15930348
25. L Ein-Dor O Zuk E Domany 2006 Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer Proc Natl Acad Sci USA 103 15 5923 5928 10.1073/pnas.0601231103 10.1073/pnas.0601231103 1:CAS:528:DC%2BD28XktFaitLo%3D 16585533
26. YJ Miyazaki J Hamada M Tada, et al. 2002 HOXD3 enhances motility and invasiveness through the TGF-beta-dependent and -independent pathways in A549 cells Oncogene 21 5 798 808 10.1038/sj.onc.1205126 10.1038/sj.onc.1205126 1:CAS:528:DC%2BD38Xht1Srurk%3D 11850808
27. K Inamura Y Togashi M Okui, et al. 2007 HOXB2 as a novel prognostic indicator for stage I lung adenocarcinomas J Thoracic Oncol 2 9 802 807 10.1097/JTO.0b013e3181461987 10.1097/JTO.0b013e3181461987